Hospital PUC-Campinas

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Crohn's disease1 trial
• High blood pressure1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  NCT05509777· Phase 3· Eli Lilly and Company· Source

  Contact: Joaquim Simoes Neto (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting
• High blood pressure1 recruiting
• Type 2 diabetes1 recruiting